Switching from vitamin K antagonists to direct oral anticoagulants: Treatment satisfaction and patient concerns.

ABSTRACT:

Background

Since direct oral anticoagulants (DOACs) have been introduced for treatment and prevention of thromboembolic diseases, patients on vitamin K antagonists (VKA) have to decide whether to remain on VKA or switch to DOAC. The goal of this study was to evaluate treatment satisfaction, preferences, and concerns among those who already have switched from VKA to DOAC.

Methods

A questionnaire was sent to 2920 former patients of three anticoagulation clinics in the Netherlands, who switched from VKA to DOAC (2016-2017). Questions concerned demographics, treatment satisfaction, concerns, perspectives on antidotes, and monitoring. To identify predictors for being concerned about adverse events, logistic regression was used to estimate crude- and adjusted (age and sex) odds ra

SUBMITTER: Toorop MMA 

PROVIDER: S-EPMC7318134 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature